Light therapy shows promise for ataxia symptoms in early trial

NCT ID NCT07296068

Not yet recruiting Symptom relief Sponsor: University of Central Lancashire Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether shining red and near-infrared light on the scalp (photobiomodulation) can temporarily improve balance and cognitive function in 20 adults with ataxia. Participants will receive either active light or a sham device in a randomized, placebo-controlled design. The goal is to see if this safe, non-invasive approach is worth studying further for symptom relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Photobiomodulation (light therapy)
What this could lead to: If it works, this could point toward a safe, non-drug way to temporarily improve balance and concentration in people with ataxia.
What could go wrong: This is a very small pilot study (20 people) testing only immediate effects. It may show no benefit, and any improvements might not last or apply to everyone with ataxia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ataxia cerebellar ataxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATAXIA

Contacts and locations

Locations

University of Central Lancashire

Preston, Lancashire, PR1 2HE, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.